Alexandra Gaspar | Medicinal chemistry | Women Researcher Award

Published on by Environmental Scientists

Women Researcher Award

Alexandra Gaspar
Faculty of Sciences, University of Porto
Alexandra Gaspar
Affiliation Faculty of Sciences, University of Porto
Country Portugal
Scopus ID 7102545856
Documents 56
Citations 3157
h-index 25
Subject Area Medicinal chemistry
Event Environmental Scientists Award
ORCID
0000-0002-3892-4124

Alexandra Gaspar distinguished scholarly contributions and sustained academic achievements in scientific research and innovation. Alexandra Gaspar, affiliated with the Faculty of Sciences at the University of Porto, Portugal, has contributed to the advancement of medicinal chemistry through interdisciplinary research, publication activity, and scientific collaboration. Her academic profile reflects a sustained commitment to pharmaceutical sciences, molecular design, and medicinal chemistry applications relevant to environmental and biomedical challenges.[1]

Abstract

Alexandra Gaspar has established a recognized academic profile in medicinal chemistry, with scholarly activities emphasizing pharmaceutical innovation, bioactive molecular development, and interdisciplinary scientific applications. Her publication record, citation performance, and international research visibility demonstrate active engagement in medicinal and pharmaceutical sciences. Through contributions to peer-reviewed literature and collaborative scientific research, her work has supported ongoing developments in molecular therapeutics and chemical biology.[1][2]

Keywords

Women Researcher Award, Medicinal Chemistry, Pharmaceutical Sciences, Drug Discovery, Portugal, University of Porto, Molecular Design, Chemical Biology, Environmental Scientists Award, Scientific Research

Introduction

Medicinal chemistry remains an important interdisciplinary scientific field integrating chemistry, biology, and pharmaceutical sciences to support therapeutic development and molecular innovation. Researchers working in this area contribute to the design, synthesis, and evaluation of compounds with biological relevance. Alexandra Gaspar’s academic activities align with these objectives through investigations related to pharmaceutical compounds and medicinal chemistry methodologies. Her research profile reflects a combination of scientific productivity and international academic engagement within biomedical and pharmaceutical research domains.[1]

Research Profile

Alexandra Gaspar is associated with the Faculty of Sciences at the University of Porto in Portugal, where she has contributed to medicinal chemistry research and related pharmaceutical sciences. Her Scopus author profile documents 56 indexed publications with a citation count exceeding 3,100 and an h-index of 25, indicating notable scholarly visibility within the scientific community.[1]

Her academic work includes collaboration across interdisciplinary research environments and contributions to studies involving biologically active compounds, medicinal chemistry strategies, and molecular therapeutic investigations. These activities have contributed to the dissemination of scientific findings in peer-reviewed journals and international academic platforms.[2]

Research Contributions

The research contributions associated with Alexandra Gaspar encompass medicinal chemistry applications and pharmaceutical compound investigations. Her work has included the evaluation of molecular structures, chemical synthesis approaches, and studies associated with therapeutic and biological activities. Such investigations contribute to broader scientific understanding in medicinal and pharmaceutical chemistry.

  • Research involving medicinal chemistry and pharmaceutical sciences.
  • Contributions to peer-reviewed scientific publications and collaborative studies.
  • Participation in interdisciplinary molecular and therapeutic research initiatives.
  • Scientific dissemination through academic journals and international research platforms.

Publications

Alexandra Gaspar has contributed to scientific literature indexed in major academic databases. Selected publication themes include medicinal chemistry, molecular therapeutics, and pharmaceutical research methodologies. Her publication activity has contributed to citation visibility and scholarly engagement within the biomedical sciences community.[2]

  • Studies related to medicinal and pharmaceutical chemistry.
  • Research on biologically active molecules and therapeutic applications.

Research Impact

The citation performance and h-index associated with Alexandra Gaspar’s academic record indicate measurable scholarly influence within medicinal chemistry and pharmaceutical research. Citation metrics frequently reflect research visibility, scientific utilization, and interdisciplinary engagement. Her publication profile demonstrates continued participation in international scientific communication and collaborative knowledge production.[1]

Research impact in medicinal chemistry also extends to the development of methodologies and scientific approaches supporting biomedical and pharmaceutical innovation. Contributions within these areas are important for advancing scientific understanding and supporting future therapeutic investigations.

Award Suitability

Alexandra Gaspar’s scholarly profile aligns with the objectives of the Women Researcher Award due to her sustained research activity, publication performance, and scientific contributions within medicinal chemistry. Her academic engagement demonstrates participation in internationally relevant scientific research and interdisciplinary collaboration. The combination of publication productivity, citation impact, and institutional affiliation supports recognition within the Environmental Scientists Award framework.[1][2]

Conclusion

The Women Researcher Award article for Alexandra Gaspar presents a structured overview of her academic profile, research achievements, and scholarly visibility within medicinal chemistry. Her scientific activities demonstrate continued participation in pharmaceutical and biomedical research, with measurable citation impact and publication engagement. The profile reflects a contribution to scientific advancement consistent with international academic recognition standards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Alexandra Gaspar, Author ID 7102545856. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102545856
  2. ORCID. (n.d.). Alexandra Gaspar ORCID profile.
    https://orcid.org/0000-0002-3892-4124
  3. Gaspar, A., & Garrido, J. M. P. J. (2026). Unveiling RNA ligands: Harnessing NMR for hit generation.European Journal of Medicinal Chemistry.Β  https://www.sciencedirect.com/science/article/abs/pii/S0223523425012607?via%3Dihub
  4. Gaspar, A., Garrido, E. M. P. J., Borges, F., & Garrido, J. M. P. J. (2024). Biological and medicinal properties of natural chromones and chromanones. https://pubs.acs.org/doi/10.1021/acsomega.4c00771
  5. Silva, V. F. M., Silva, A., Garrido, E. M. P. J., Borges, F., Gaspar, A., & Garrido, J. M. P. J. (2024). Microencapsulation of the biocide benzisothiazolinone (BIT) by inclusion in methyl-Ξ²-cyclodextrin and screening of its antibacterial and ecotoxicity properties. https://www.mdpi.com/2305-6304/12/9/674

Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

Published on by Environmental Scientists

Dr. Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

PhD candidate, Institute of drug discovery and development, Zhengzhou University, China

Nigatu Tadesse Gebrehiwot is a dedicated clinical pharmacist and PhD candidate in Pharmacology at Zhengzhou University, China πŸ‡¨πŸ‡³. With a strong background in drug safety, cancer care, and clinical trials, he combines research, patient-centered care, and academic writing to advance pharmaceutical sciences. Fluent in English (CEFR: C2) and well-versed in pharmacotherapy, Nigatu is recognized for his interdisciplinary expertise and contributions to national and international healthcare initiatives πŸŒπŸ’Š.

Profile

Orcid

πŸŽ“ Education

Nigatu earned his Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University πŸ‡¨πŸ‡³ (2016–2019), where he was honored for presenting research at the ISPOR European Congress in Barcelona. He completed his Bachelor of Pharmacy at Mekelle University πŸ‡ͺπŸ‡Ή (2009–2014), where he was celebrated as the most outstanding student. His academic journey reflects consistent excellence and passion for clinical research and therapeutic outcomes πŸ“šπŸ….

πŸ§ͺ Experience

Nigatu has held various impactful roles in healthcare and pharmaceutical research. As Principal Scientific Officer at Ethiopia’s Ministry of Health πŸ‡ͺπŸ‡Ή, he led disease management and national drug therapy protocols. He also served as Technical Manager at CBC Pharmacy, oversaw clinical pharmacy at Teklehaiymanot Hospital, and advised over 50 drug access projects for the Chinese market 🌍. Currently, he is pursuing a PhD in Pharmacology at Zhengzhou University, specializing in drug safety and clinical outcomes πŸ”¬πŸ©Ί.

πŸ”¬ Research Interest

Nigatu’s research interests span methionine metabolism in cancer, therapeutic drug evaluation, clinical trial outcomes, and antimicrobial therapy. He is particularly focused on immunotherapy, functional disease outcome measures, and innovative diagnostic methods. His goal is to improve patient care through translational and evidence-based pharmaceutical research πŸ’‘πŸ§¬.

πŸ† Awards

Nigatu received an award for his research abstract at the 21st European Congress ISPOR in Barcelona, Spain πŸ‡ͺπŸ‡Έ. He’s been acknowledged nationally and internationally for his scientific contributions and health policy initiatives. His ongoing membership in global societies like ISPOR, ISOPP, and ESMO underlines his excellence in pharmacology and healthcare outcome research πŸ₯‡πŸŒ.

πŸ“š Publications

Molecular Alterations in Gastric Intestinal Metaplasia (2025) – Biomedicines, 13(4):964
πŸ”— Read Article

Folate Species Analysis Challenges – Under revision in Bioanalysis

Methionine Metabolism in Immunotherapy – Under review in Novel Practice in Medical Study

Dioscorea zingiberensis Overview (2018) – Journal of Ethnopharmacology
πŸ”— Read Article

Toxicity of Dioscorea Extracts in Dogs (2017) – Regulatory Toxicology and Pharmacology
πŸ”— Read Article

Amide Alkaloid Synthesis and Anticancer Activity (2017) – Journal of Natural Product Research
πŸ”— Read Article

Wastewater Treatment in Diosgenin Production (2018) – Journal of Cleaner Production
πŸ”— Read Article

Antibiotic Prescribing in Sierra Leone – Royal Society of Tropical Medicine and Hygiene
πŸ”— Read Article

Self-Medication in Addis Ababa – Expert Review of Anti-infective Therapy
πŸ”— Read Article

Survival Time in HIV/TB Co-infection – Value in Health
πŸ”— Read Article

πŸ“ Conclusion

Mr. Nigatu Tadesse Gebrehiwot presents a strong and well-rounded profile suitable for the Best Researcher Award, especially within clinical pharmacology, health outcomes research, and drug safety. His multidisciplinary expertise, global engagement, and impactful publications showcase his excellence. With continued leadership in original research and enhanced visibility as principal investigator, he can solidify his position among the top-tier researchers internationally.

Shamma Almuraikhy | drug design | Best Researcher Award

Published on by Environmental Scientists

Dr. Shamma Almuraikhy | drug design | Best Researcher Award

Senior research assistant, Qatar university, Qatar

Shamma Abdullah AL Muraikhy is a distinguished Qatari academic and researcher currently working as a Senior Research Assistant at the Biomedical Research Centre at Qatar University. With a background in clinical laboratory sciences, Shamma has dedicated her career to advancing research in the fields of exercise science, insulin resistance, and type 2 diabetes. She holds a Ph.D. in Drug Design from the University of Groningen (Netherlands), a Master of Science from the University of Bristol (UK), and a Bachelor’s degree in Clinical Laboratory Sciences from Imam Abdulrahman Bin Faisal University (Saudi Arabia). Her research work focuses on molecular techniques, including metabolomics, and its applications in insulin resistance and other metabolic disorders. She has contributed significantly to several research projects and publications, making her an expert in her field. πŸ§‘β€πŸ”¬πŸ“š

Publication Profile

Google Scholar

Education:

Shamma holds a Ph.D. in Drug Design from the University of Groningen, Netherlands (2021–2024). Her Master’s in Science was obtained from the University of Bristol, UK (2015–2017). She completed her Bachelor’s in Clinical Laboratory Sciences (Formerly Medical Laboratory Technology) at Imam Abdulrahman Bin Faisal University (Saudi Arabia) between 1993 and 1997. πŸŽ“πŸŒ

Experience:

Shamma’s professional career spans over two decades, beginning with her work as a Medical Lab Technologist at King Fahd Teaching Hospital (Saudi Arabia) in 1998. She later worked as a Senior Lab Technologist at ARAMCO Hospital (Saudi Arabia). Over the years, Shamma held various significant roles, including Senior Research Scientist and Risk & Quality Officer at the Anti-Doping Lab in Qatar. Currently, she serves as a Senior Research Assistant at the Biomedical Research Centre, Qatar University. πŸ₯πŸ”¬

Awards and Honors:

Shamma’s academic and research contributions have earned her numerous accolades. These include multiple research grants and honors, such as being a prominent investigator in several national research projects on insulin resistance, diabetes, and exercise science. Her work is highly regarded in her field, with her publications cited in several international journals. πŸ†βœ¨

Research Focus:

Shamma’s research is at the intersection of exercise science, molecular biology, and metabolic disorders. Her primary research focus includes investigating insulin resistance, adipogenesis, and diabetes. She has explored various molecular mediators involved in exercise-induced insulin sensitivity and the role of inflammatory biomarkers and oxidative stress in athletes. She is also focused on understanding how exercise and fasting may influence telomere length and cellular aging, and her work on GATA-3 as a potential therapeutic target for insulin resistance is groundbreaking. πŸ”¬πŸ’ͺ

Conclusion:

Shamma Abdullah AL Muraikhy is a leading researcher in the fields of exercise science and metabolic health. With a robust academic background, extensive professional experience, and a passion for improving our understanding of insulin resistance and diabetes, Shamma continues to make significant contributions to scientific research. Her work is poised to influence future therapeutic strategies and interventions for metabolic diseases. πŸŒŸπŸ“ˆ

Publications:

Metabolic signature of leukocyte telomere length in elite male soccer players
Shamma Al-Muraikhy, Maha Sellami, Alex Domling, et al.
Front. Mol. Biosci., December 2021, Vol. 8
Link to publication

High endurance elite athletes show age-dependent lower levels of circulating complements compared to low/moderate endurance elite athletes
Shamma Al-Muraikhy, Manjunath Ramanjaneya, Alexander S. DΓΆmling, et al.
Front. Mol. Biosci., September 2021, Vol. 8
Link to publication

Molecular regulators of exercise-mediated insulin sensitivity in non-obese individuals (review paper)
Shamma AlMuraikhy, Asmaa Doudin, Alexander Domling, et al.
J Cell Mol Med, 2023
Link to publication

Comparing the Metabolic Profiles Associated with Fitness Status between Insulin-Sensitive and Insulin Resistant Non-Obese Individuals
Shamma AlMuraikhy, Najeha Anwardeen, Aisha Naeem, et al.
Int. J. Environ. Res. Public Health, 2022, 19(19), 12169
Link to publication

The Metabolic Switch of Physical Activity in Non-Obese Insulin Resistant Individuals
Shamma Almuraikhy, Najeha Anwardeen, Asmma Doudin, et al.
Int. J. Mol. Sci., 2023, 24(9), 7816
Link to publication

Antioxidative Stress Metabolic Pathways in Moderately Active Individuals
Shamma Almuraikhy, Najeha Anwardeen, Asmaa Doudin, et al.
Metabolites, September 2023, 13(9): 973
Link to publication

Impact of Moderate Physical Activity on Inflammatory Markers and Telomere Length in Sedentary and Moderately Active Individuals with Varied Insulin Sensitivity
Shamma Almuraikhy, Maha Sellami, Hadaia Saleh Al-Amri, et al.
J Inflamm Res., 2023, 16: 5427-5438
Link to publication

Eight weeks of aerobic exercise, but not four, improves insulin sensitivity and cardiovascular performance in young women
Maha Sellami, Shamma Almuraikhy, Khaled Naja, et al.
Submitted

Joint Effects of Exercise and Fasting on Telomere Length: Implications for Cellular Aging
Shamma Almuraikhy, Maha Sellami, Khaled Naja, et al.
Biomedicines, May 2024, 12(6): 1182
Link to publication

Metabolic signatures of combined exercise and fasting: An expanded perspective on previous telomere length
Shamma Almuraikhy, Khaled Naja, Najeha Rizwana Anwardeen, et al.
Frontiers
Link to publication